先天性长QT综合征患者剧烈运动的前瞻性多国观察研究:LIVE-LQTS结果
LIVE-LQTS研究前瞻性纳入5国37个中心1413例表型和/或基因型长QT综合征患者(8-60岁),随访3年,比较剧烈运动者与非剧烈运动者的复合终点事件。剧烈运动组3年事件率2.6%,非剧烈运动组2.7%,校正后HR 1.17(90%CI 0.67-2.04),但非劣效性未证实,因置信区间宽。
要点
- 在经验丰富中心评估治疗的长QT综合征患者中,剧烈运动者与非剧烈运动者心脏事件率低且相似。
- 剧烈运动定义≥6代谢当量且每年>60小时,52%患者参与,其中55%为竞技运动。
- 非劣效性未证实,置信区间宽,需个体化共同决策讨论运动参与。
核心结论
- 在经风险评估和治疗的长QT综合征患者中,剧烈运动与非剧烈运动者的LQTS相关心脏事件率低且相似,但非劣效性未证实。
研究设计与样本
- NIH资助的前瞻性观察性多国研究LIVE-LQTS,2015年5月至2019年2月从5国37个中心纳入8-60岁表型和/或基因型LQTS患者1413例,随访3年。
主要发现
- 1413例参与者中52%参与剧烈运动,37例发生复合终点事件(剧烈运动组1例心脏骤停,非剧烈运动组1例心脏骤停和1例猝死)。
- 3年总体事件率剧烈运动组2.6%,非剧烈运动组2.7%。
- 未校正HR 0.97(90%CI 0.57-1.67),校正后HR 1.17(90%CI 0.67-2.04)。
- 单侧95%置信上限超出1.5非劣效界值,非劣效性未证实。
- 任何组或亚组中未发现剧烈运动或非剧烈运动更优。
关键数值与推荐
- 剧烈运动定义为≥6代谢当量且每年>60小时。
- 复合终点包括猝死、心脏骤停、植入式心律转复除颤器治疗的室性心律失常和可能心律失常性晕厥。
- 非劣效性界值为1.5,采用多变量Cox回归分析检验。
临床怎么用
- 对于经经验丰富中心风险评估和治疗的长QT综合征患者,剧烈运动的心脏事件率低,可与患者共同决策讨论运动和竞技体育参与。
- 需注意非劣效性未证实,置信区间宽,应个体化评估。
局限性
- 观察性研究,事件率低导致置信区间宽,非劣效性未证实。
- 结果可能不适用于未在经验丰富中心评估治疗的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether vigorous exercise increases risk of ventricular arrhythmias for individuals diagnosed and treated for congenital long QT syndrome (LQTS) remains unknown. METHODS: The National Institutes of Health-funded LIVE-LQTS study (Lifestyle and Exercise in the Long QT Syndrome) prospectively enrolled individuals 8 to 60 years of age with phenotypic and/or genotypic LQTS from 37 sites in 5 countries from May 2015 to February 2019. Participants (or parents) answered physical activity and clinical events surveys every 6 months for 3 years with follow-up completed in February 2022. Vigorous exercise was defined as ≥6 metabolic equivalents for >60 hours per year. A blinded Clinical Events Committee adjudicated the composite end point of sudden death, sudden cardiac arrest, ventricular arrhythmia treated by an implantable cardioverter defibrillator, and likely arrhythmic syncope. A National Death Index search ascertained vital status for those with incomplete follow-up. A noninferiority hypothesis (boundary of 1.5) between vigorous exercisers and others was tested with multivariable Cox regression analysis. RESULTS: Among the 1413 participants (13% <18 years of age, 35% 18-25 years of age, 67% female, 25% with implantable cardioverter defibrillators, 90% genotype positive, 49% with LQT1, 91% were treated with beta-blockers, left cardiac sympathetic denervation, and/or implantable cardioverter defibrillator), 52% participated in vigorous exercise (55% of these competitively). Thirty-seven individuals experienced the composite end point (including one sudden cardiac arrest and one sudden death in the nonvigorous group, one sudden cardiac arrest in the vigorous group) with overall event rates at 3 years of 2.6% in the vigorous and 2.7% in the nonvigorous exercise groups. The unadjusted hazard ratio for experience of events for the vigorous group compared with the nonvigorous group was 0.97 (90% CI, 0.57-1.67), with an adjusted hazard ratio of 1.17 (90% CI, 0.67-2.04). The upper 95% one-sided confidence level extended beyond the 1.5 boundary. Neither vigorous or nonvigorous exercise was found to be superior in any group or subgroup. CONCLUSIONS: Among individuals diagnosed with phenotypic and/or genotypic LQTS who were risk assessed and treated in experienced centers, LQTS-associated cardiac event rates were low and similar between those exercising vigorously and those not exercising vigorously. Consistent with the low event rate, CIs are wide, and noninferiority was not demonstrated. These data further inform shared decision-making discussions between patient and physician about exercise and competitive sports participation. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02549664.
引用
- Lampert R, Day S, Ainsworth B, et al. Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study. Circulation. 2024. PMID: 39051104. doi:10.1161/CIRCULATIONAHA.123.067590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。